Heidelberg Pharma AG (ETR:HPHA)
Germany flag Germany · Delayed Price · Currency is EUR
2.080
-0.070 (-3.26%)
Oct 26, 2026, 5:35 PM CET

Heidelberg Pharma AG Ratios and Metrics

Millions EUR. Fiscal year is Dec - Nov.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
97136112129266177
Market Cap Growth
-28.27%21.70%-13.03%-51.73%50.53%9.59%
Enterprise Value
781137584272164
Last Close Price
2.082.912.402.765.725.18

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
PS Ratio
10.4493.4116.3313.0514.3987.04
PB Ratio
--12.473.622.614.0026.43
P/TBV Ratio
--5.083.184.62-

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
EV/Sales Ratio
8.3577.8011.028.4914.6880.41

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Debt / Equity Ratio
-0.01-0.010.010.120.241.59
Net Debt / Equity Ratio
1.011.36-0.95-0.76-0.980.67
Net Debt / EBITDA Ratio
0.600.311.391.403.69-0.18
Net Debt / FCF Ratio
1.020.470.971.096.92-0.16
Asset Turnover
0.190.030.110.120.300.10
Inventory Turnover
0.140.020.160.431.769.66
Quick Ratio
2.961.514.402.312.960.51
Current Ratio
4.242.535.952.863.150.60
Return on Equity (ROE)
--423.92%-48.33%-35.09%-53.73%-267.02%
Return on Assets (ROA)
-42.36%-61.88%-20.82%-20.14%-18.70%-78.14%
Return on Capital Employed (ROCE)
-94.00%-181.70%-41.40%-54.50%-25.20%-380.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Earnings Yield
-31.57%-31.06%-17.33%-15.82%-7.39%-14.77%
FCF Yield
-19.64%-23.31%-26.86%-26.91%-3.55%-15.74%
Buyback Yield / Dilution
2.91%-0.14%-0.02%-25.14%-14.56%-8.72%